Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MediciNova Inc

+ Add to Watchlist

MNOV:US

4.4500 USD 0.5100 10.28%

As of 20:10:00 ET on 04/17/2015.

Snapshot for MediciNova Inc (MNOV)

Open: 4.9000 Day's Range: 4.3100 - 4.9000 Volume: 762,530
Previous Close: 4.9600 52wk Range: 1.7200 - 5.9000 1-Yr Rtn: +130.57%

Stock Chart for MNOV

No chart data available.
  • MNOV:US 4.4500
  • 1D
  • 1M
  • 1Y
4.9600
Interactive MNOV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNOV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3800
Est. EPS (USD) (12/2015) -0.3300
Est. PEG Ratio -
Market Cap (M USD) 109.54
Shares Outstanding (M) 24.62
30 Day Average Volume 284,704
Price/Book (mrq) 4.9409
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNOV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNOV

MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. The Company, through alliances with Japanese pharmaceutical companies, has built a portfolio of drug candidates. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.

Yuichi IwakiPresident/CEO/FounderVan Den BoomChief Financial Officer
Kazuko MatsudaChief Medical OfficerMasatsune OkajimaVP/Head:Japanese Office
More Company Profile & Key Executives for MNOV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil